github link
Accession IconGSE22968

Phase II trial melphalan ILI plus ADH-1 for treatment of in-transit extremity melanoma

Organism Icon Homo sapiens
Sample Icon 27 Downloadable Samples
Technology Badge Icon Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Submitter Supplied Information

Description
An evaluation of biopsies from patients with in-transit extremity melanoma who have been treated with ADH-1 followed by melphalan in the setting of isolated limb infusion
PubMed ID
Total Samples
28
Submitter’s Institution

Samples

Show of 0 Total Samples
Filter
Add/Remove
Accession Code
Title
Disease
Disease stage
Treatment
Processing Information
Additional Metadata
No rows found
Loading...